Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet’s disease

[1]  A. Kijlstra,et al.  Specific sweat metabolite profile in ocular Behcet's disease. , 2021, International immunopharmacology.

[2]  J. Rivera-Nieves,et al.  Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis , 2021, Drugs.

[3]  A. Kijlstra,et al.  Metabolomic Analysis of Aqueous Humor Identifies Aberrant Amino Acid and Fatty Acid Metabolism in Vogt-Koyanagi-Harada and Behcet’s Disease , 2021, Frontiers in Immunology.

[4]  C. Barbas,et al.  Dysregulation of glycerophospholipid metabolism during Behçet’s disease contributes to a pro-inflammatory phenotype of circulating monocytes , 2020, Journal of translational autoimmunity.

[5]  Md. Asiful Islam,et al.  Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis , 2020, PloS one.

[6]  K. Kim,et al.  Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis. , 2020, Clinical and experimental rheumatology.

[7]  A. Atwater,et al.  Shifting Paradigms in Allergic Contact Dermatitis: The Role of Innate Immunity. , 2020, The Journal of investigative dermatology.

[8]  S. Park,et al.  Lipidomic profiles disturbed by the internet gaming disorder in young Korean males. , 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  K. Kim,et al.  Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variants , 2019, Scientific Reports.

[10]  Zhili Li,et al.  In situ detecting changes in membrane lipid phenotypes of macrophages cultured in different cancer microenvironments using mass spectrometry. , 2018, Analytica chimica acta.

[11]  P. Convertini,et al.  New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation , 2018, Mediators of inflammation.

[12]  M. Ralli,et al.  Behçet's disease: New insights into pathophysiology, clinical features and treatment options. , 2018, Autoimmunity reviews.

[13]  M. Orešič,et al.  Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells , 2018, Front. Mol. Biosci..

[14]  K. Kim,et al.  Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry. , 2017, Joint, bone, spine : revue du rhumatisme.

[15]  Do Yup Lee,et al.  Simple and Robust Measurement of Blood Plasma Lysophospholipids Using Liquid Chromatography Mass Spectrometry , 2017 .

[16]  O. Fiehn,et al.  Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets , 2017, Scientific Reports.

[17]  K. Kim,et al.  Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet’s Disease by Gas Chromatography/Time-of-Flight−Mass Spectrometry , 2017, International journal of molecular sciences.

[18]  C. Chalfant,et al.  Lipidomics in translational research and the clinical significance of lipid-based biomarkers. , 2017, Translational research : the journal of laboratory and clinical medicine.

[19]  D. Cicek,et al.  Activity Criteria in Behçet’s Disease , 2017 .

[20]  B. Hudson,et al.  Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  K. Kim,et al.  Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNS , 2016, PloS one.

[22]  Sun Park,et al.  MicroRNAs differentially expressed in Behçet disease are involved in interleukin-6 production , 2016, Journal of Inflammation.

[23]  M. Han,et al.  Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation , 2016, Drugs.

[24]  V. Chiurchiù.  Endocannabinoids and Immunity , 2016, Cannabis and cannabinoid research.

[25]  G. Kalkan,et al.  Diagnostic Value of HbA1c Level in Behcet's Disease and Evaluation of Neutrophil-Lymphocyte Ratio, Mean Platelet Volume and Body Mass Index , 2015 .

[26]  E. Remmers,et al.  The immunogenetics of Behçet's disease: A comprehensive review. , 2015, Journal of autoimmunity.

[27]  K. Kim,et al.  A Comparative Metabolomic Evaluation of Behcet’s Disease with Arthritis and Seronegative Arthritis Using Synovial Fluid , 2015, PloS one.

[28]  K. Yudoh,et al.  Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Behçet's disease. , 2014, Clinical and experimental rheumatology.

[29]  Javier Martín,et al.  HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population , 2013, Arthritis Research & Therapy.

[30]  A. Snider.  Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease. , 2013, International journal of clinical rheumatology.

[31]  B. Miller,et al.  Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean , 2013, Diabetology & Metabolic Syndrome.

[32]  K. Taskén,et al.  Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells , 2013, Front. Immunol..

[33]  M. González-Escribano,et al.  HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population , 2012, Journal of Translational Medicine.

[34]  O. Ozhan,et al.  Behcet's Disease and Endocrine System , 2011, Pathology research international.

[35]  V. Bochkov,et al.  Generation and biological activities of oxidized phospholipids. , 2010, Antioxidants & redox signaling.

[36]  Ying Xu,et al.  Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning , 2009, The Journal of experimental medicine.

[37]  Stefan R. Bornstein,et al.  Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients , 2009, PloS one.

[38]  H. Harizi,et al.  Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. , 2008, Trends in molecular medicine.

[39]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[40]  H. Direskeneli.  Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? , 2006, Rheumatology.

[41]  S. Androudi.  Current concepts in the etiology and treatment of Behçet disease. , 2006, Survey of ophthalmology.

[42]  R. Curi,et al.  Comparative toxicity of oleic and linoleic acid on human lymphocytes. , 2006, Life sciences.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[44]  I. Heilbron,et al.  Ether-linked lipids and their bioactive species , 2003 .

[45]  O. Witte,et al.  Lysophosphatidylcholine as a ligand for immunoregulation. , 2002, Biochemical pharmacology.

[46]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[47]  J. Frostegård,et al.  Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet‐activating factor (PAF) receptor‐dependent mechanism , 1999, Clinical and experimental immunology.

[48]  F. Snyder.  Chapter 7 - Ether-linked lipids and their bioactive species: occurrence, chemistry, metabolism, regulation, and function , 1996 .

[49]  K. Waku,et al.  Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes. , 1990, Biochimica et biophysica acta.

[50]  K. Cantell,et al.  Effect of Interferon on Glucose Tolerance and Insulin Sensitivity , 1989, Diabetes.

[51]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[52]  G. Hatemi,et al.  Behçet syndrome , 2021, Nature Reviews Disease Primers.